IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET

Rhea-AI Summary

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), a medical cannabis company operating in Israel and Germany, has announced it will release its third quarter 2024 financial results on November 14, 2024, before market opening. The company will host a zoom conference at 9:00am ET on the same day to discuss the results and conduct a Q&A session with investors. A recording of the call will be available on the company's investor website within 24 hours after the event.

TORONTO and GLIL YAM, Israel, Nov. 6, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third 2024 ended September 30, 2024, on November 14, 2024, before the market opens.

The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration.

If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com/ within 24 hours after the call.

Link for the to register for the zoom call: https://us02web.zoom.us/webinar/register/WN_1McuNcK_R62gmx7a3BplLg#/registration

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has focused its resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Logo - https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Company Contact:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de

Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504
info@imcannabis.com

View original content:https://www.prnewswire.com/news-releases/im-cannabis-to-report-third-quarter-2024-financial-results-on-thursday-november-14th-at-900am-et-302297445.html

SOURCE IM Cannabis Corp.

FAQ

When will IM Cannabis (IMCC) report Q3 2024 earnings?

IM Cannabis will report its Q3 2024 earnings on Thursday, November 14, 2024, before the market opens.

What time is IM Cannabis (IMCC) Q3 2024 earnings call?

IM Cannabis will host its Q3 2024 earnings call via Zoom at 9:00am ET on November 14, 2024.

Where can I find the recording of IM Cannabis (IMCC) Q3 2024 earnings call?

A recording of the earnings call will be available on the company's investor website (investors.imcannabis.com) within 24 hours after the call.